Idera Pharmaceuticals Inc (IDRA.OQ) Quote| Reuters.com
Edition:
United States

Idera Pharmaceuticals Inc (IDRA.OQ)

IDRA.OQ on NASDAQ Stock Exchange Capital Market

1.57USD
12:27pm EDT
Change (% chg)

$0.04 (+2.61%)
Prev Close
$1.53
Open
$1.53
Day's High
$1.60
Day's Low
$1.53
Volume
36,036
Avg. Vol
138,583
52-wk High
$4.42
52-wk Low
$1.20

IDRA.OQ

Chart for IDRA.OQ

About

Idera Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapeutics for oncology and rare diseases. The Company utilizes two drug discovery technology platforms to design and develop drug candidates, which include Toll-like receptor (TLR) targeting... (more)

Overall

Beta: 2.76
Market Cap(Mil.): $185.60
Shares Outstanding(Mil.): 121.31
Dividend: --
Yield (%): --

Financials

  IDRA.OQ Industry Sector
P/E (TTM): -- 42.29 36.15
EPS (TTM): -0.41 -- --
ROI: -51.92 -6.23 14.31
ROE: -52.59 -5.61 15.51

BRIEF-Idera Pharmaceuticals reports Q1 loss per share $0.11

* Idera pharmaceuticals reports first quarter 2016 financial results and provides corporate update

May 09 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : New Constructs, LLC
$25.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : Stock Traders Daily
$20.00
Provider : ValuEngine, Inc.
$25.00
Provider : S&P Capital IQ Quantitative Report
$104.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.